Related Experiment Video
Updated: May 6, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease
János Nemcsik1, István Kiss, András Tislér
1János Nemcsik, Department of Family Medicine, Semmelweis University, 1125 Budapest, Hungary.
Insights
Chronic kidney disease (CKD) accelerates arterial stiffness and calcification, linked to impaired bone metabolism. This review explores the bone-vascular axis in CKD, detailing factors influencing vascular calcification and arterial stiffness.
Area of Science:
- Nephrology
- Cardiology
- Bone Metabolism
Background:
- Patients with chronic kidney disease (CKD) exhibit significantly worse cardiovascular outcomes.
- Arterial stiffness, a key predictor of survival in CKD, is closely associated with arterial media calcification.
- The progression of arterial calcification and stiffness in CKD occurs concurrently with disturbed bone metabolism.
Purpose of the Study:
- To elucidate the mechanisms driving increased arterial stiffness in CKD.
- To present current data on the bone-vascular axis within the context of CKD.
- To review factors contributing to vascular calcification and their impact on arterial stiffness.
Main Methods:
- Literature review of scientific results.
- Analysis of the bone-vascular axis in CKD.
- Overview of factors influencing vascular calcification and arterial stiffness.
Main Results:
- CKD is characterized by increased arterial calcification and stiffness, paralleled by impaired bone metabolism.
- A complex interplay exists between bone metabolism and vascular health in CKD, termed "CKD mineral bone disorder".
- Several bone-related factors, including osteoprotegerin, fetuin-A, and fibroblast growth factor 23, are implicated in vascular calcification and arterial stiffness.
Conclusions:
- The "CKD mineral bone disorder" highlights the strong connection between bone and vascular pathologies in CKD.
- Understanding the bone-vascular axis is crucial for managing cardiovascular risks in CKD patients.
- Further research into specific bone-related factors may reveal therapeutic targets for reducing arterial stiffness and calcification in CKD.
Abstract:
Patients with chronic kidney disease (CKD) have an extremely poor cardiovascular outcome. Arterial stiffness, a strong independent predictor of survival in CKD, is connected to arterial media calcification. A huge number of different factors contribute to the increased arterial calcification and stiffening in CKD, a process which is in parallel with impaired bone metabolism. This coincidence was demonstrated to be part of the direct inhibition of calcification in the vessels, which is a counterbalancing effect but also leads to low bone turnover. Due to the growing evidence, the definition of "CKD mineral bone disorder" was created recently, underlining the strong connection of the two phenomena. In this review, we aim to demonstrate the mechanisms leading to increased arterial stiffness and the up-to date data of the bone-vascular axis in CKD. We overview a list of the different factors, including inhibitors of bone metabolism like osteoprotegerin, fetuin-A, pyrophosphates, matrix Gla protein, osteopontin, fibroblast growth factor 23 and bone morphogenic protein, which seem to play role in the progression of vascular calcification and we evaluate their connection to impaired arterial stiffness in the mirror of recent scientific results.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

